Skip to content

Voice Analysis in Women With Polycystic Ovary Syndrome

Voice Analysis in Women With Polycystic Ovary Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06085170
Enrollment
50
Registered
2023-10-16
Start date
2023-12-31
Completion date
2024-02-29
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Voice Change

Brief summary

Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to one in five reproductive-aged women. It is associated with clinical and/or biochemical hyperandrogenism, oligomenorrhea, and polycystic appearance of ovaries in ultrasonography. Voice changes have been traditionally recognized as a feature of PCOS for years. However, voice analyses of patients with PCOS are limited. The human larynx is a highly hormone-sensitive target with the presence of hormonal receptors within the vocal folds, and vocal changes occur in relation to the fluctuations in the sex hormones. During the reproductive years and throughout the menstrual cycle, vocal changes have been reported in almost one-third of nonprofessional voice users.The aim of this work is to evaluate the voice characteristics among women with PCOS

Detailed description

Polycystic ovary syndrome (PCOS) is a common endocrine disorder affecting up to one in five reproductive-aged women. It is associated with clinical and/or biochemical hyperandrogenism, oligomenorrhea, and polycystic appearance of ovaries in ultrasonography. Voice changes have been traditionally recognized as a feature of PCOS for years. However, voice analyses of patients with PCOS are limited. The human larynx is a highly hormone-sensitive target with the presence of hormonal receptors within the vocal folds, and vocal changes occur in relation to the fluctuations in the sex hormones. During the reproductive years and throughout the menstrual cycle, vocal changes have been reported in almost one-third of nonprofessional voice users. Hyperandrogenism is a landmark in the diagnosis of PCOS, and androgen-related voice changes in women have been recognized.The aim of this work is to evaluate the voice characteristics among women with PCOS The study will include 50 women with and without PCOS. They will divided into 2 groups. Group I will comprise of the 25 women in the clinical group diagnosed with PCOS on ultrasound, while Group II will comprise of 25 typical women as controls Patients will be selected from Obstetric gynecological clinics of El Minna University Hospital .This study is approved by the ethics committee in the Faculty of medicine, Minna university hospital, and concents will be obtained from subjects. Methods 1. History taking. 2. Abdominal ultrasonography 3. voice sample by recording (in sustained vowel \|a\| ) 4. Auditory Perceptual Assessment (APA) 5. Arabic voice handicap index (VHI): For measurement of the voice severity with the Arabic version of VHI 6. laryngoscopic examination Patients will taken to a room with a tower on which the 8.5 mm 70 rigid laryngoscopic (KARL STORZ - endoscope) (Tele pack X LED). 7. Acoustic analysis: The voice sample will be subjected to computerized acoustic analysis using Multidimensional voice program software(MDVP). The results will be presented in tables and charts.Statistical analysis:Parametric and non-parametric tests included in statistical package for social science version 19 .The level of significance for this study is at 0.05.

Interventions

DIAGNOSTIC_TESTAcoustic Analysis by MDVP

Acoustic measurements: Acoustic analysis using Multidimensional voice program software (MDVP) will be carried out with the sustained /a/vowel for 9 seconds, for measuring frequency, jitter, shimmer and harmonic to noise ratio of the voice

Sponsors

Minia University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Group I participants: * women with polycystic ovaries on ultrasound. * Group II will be: * women have a regular menstrual cycles and no PCOS on ultrasound

Exclusion criteria

* Women with hypersensitive gag reflex, * alcohol consumption, * Smoking, * reflux symptoms and vocal abuse will be excluded in both groups.

Design outcomes

Primary

MeasureTime frameDescription
frequencybaselinefrequency in hertz
jitterbaselinejitter in percentage%
shimmerbaselineshimmer in decibel
Harmonic to noise ratiobaselineHarmonic to noise ratio in decibel

Contacts

Primary ContactWafaa H Abdelhakeem, MD
dr.fofahma@gmail.com01091813874
Backup ContactHamza M Abdelmohsen, MD
dr.hany3ssawy@gmail.com01004187816

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026